title: Bladder cancer: second-line nab-paclitaxel for advanced urothelial carcinoma.
authors.forename: Sarah
authors.initials: S
authors.lastname: Payton
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy*; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D053758:Nanoparticles; D017239:Paclitaxel / Q000008:administration & dosage*; D014516:Ureteral Neoplasms / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D019459:Urothelium / Q000187:drug effects*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004337:Drug Carriers; D017239:Paclitaxel